Africa CDC Targets End-2026 Vaccine for Deadly Bundibugyo Ebola Strain Amid Rising Cases
मुख्य बातें
- •Africa CDC Director General Jean Kaseya announced on May 28, 2026, that a vaccine for the Bundibugyo Ebola strain will be ready by December 2026.
- •The Bundibugyo strain lacks any approved vaccine or treatment, making this development a significant medical milestone.
- •As of May 15, 2026, the DRC has reported 1,077 suspected Ebola cases and 246 deaths, according to Africa CDC data.
- •Uganda has reported eight confirmed Ebola cases, up from seven reported on May 27, 2026.
The Africa Centres for Disease Control and Prevention (Africa CDC) has pledged to deliver a vaccine against the Bundibugyo strain of the Ebola virus by December 2026, as the deadly outbreak in the Democratic Republic of Congo (DRC) continues to spread. Speaking to reporters during an online briefing on May 28, 2026, Africa CDC Director General Jean Kaseya confirmed that development efforts are already underway, with several vaccine candidates under consideration. “What we can tell you for sure, by the end of this year, 2026, Africa CDC will make sure that we have a vaccine and medicine against Bundibugyo,” Kaseya stated. He emphasized that African leaders are fully committed to investing both technically and strategically to ensure the vaccine becomes a reality.
